Myasthenia gravis exacerbation associated with pembrolizumab
- 12 March 2016
- journal article
- case report
- Published by Wiley in Muscle & Nerve
- Vol. 54 (3), 506-507
- https://doi.org/10.1002/mus.25055
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Influence of NSAID Use Among Colorectal Cancer Survivors on Cancer OutcomesAmerican Journal of Clinical Oncology, 2017
- Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanomaJapanese Journal of Clinical Oncology, 2015
- Myasthenia gravis associated with ipilimumab and nivolumab in the treatment of small cell lung cancerMuscle & Nerve, 2015
- Arthritis and Tenosynovitis Associated With the Anti-PD1 Antibody Pembrolizumab in Metastatic MelanomaJournal of Immunotherapy, 2015
- Atypical neurological complications of ipilimumab therapy in patients with metastatic melanomaNeuro-Oncology, 2014
- PD‐1 as a potential target in cancer therapyCancer Medicine, 2013
- ANTI-MUSK ANTIBODY AFTER THYMECTOMY IN A PREVIOUSLY SEROPOSITIVE MYASTHENIC CHILDNeurology, 2007